FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV - The Body
Links shared publicly online about this topic.
- 735total visits
FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV - The Body
On November 10, 2010, the Food and Drug Administration approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which ...
View full resource at thebody.com
Tags: HIV, AIDS, STD, Diet and Nutrition, Fat, Drug, FDA
Most Recently Shared on November 11, 2010 at 1:01 pm By:
FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV http://www.thebody.com/content/art59376.html?tw #aids #fat #hump
Advertisement
